Nanologica: Transformative acquisition & SEK96m capital raise - Redeye

Redeye comments on Nanologica following yesterday’s after-market announcement of the acquisition of CDMO Syntagon and the accompanying cSEK 96m capital raise, which comprises both a rights issue and directed share issues. Redeye will temporarily suspend coverage pending the outcome of the rights issue.

Länk till analysen i sin helhet: https://www.redeye.se/research/1146388/nanologica-transformative-acquisition-sek96m-capital-raise?utm_source=finwire&utm_medium=RSS